Reviva Pharmaceuticals Holdings Stock Today
| RVPH Stock | USD 2.80 0.14 4.76% |
Performance0 of 100
| Odds Of DistressOver 85
|
Reviva Pharmaceuticals is trading at 2.80 as of the 8th of May 2024. This is a -4.76% down since the beginning of the trading day. The stock's open price was 2.94. Reviva Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Reviva Pharmaceuticals Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of March 2024 and ending today, the 8th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of October 2018 | Category Healthcare | Classification Health Care |
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company has 27.92 M outstanding shares of which 1.23 M shares are at this time shorted by private and institutional investors with about 3.37 trading days to cover. More on Reviva Pharmaceuticals Holdings
Moving against Reviva Stock
| 0.58 | NVO | Novo Nordisk AS | PairCorr |
| 0.53 | HCWB | HCW Biologics | PairCorr |
| 0.49 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.49 | IMNN | Imunon Inc Financial Report 9th of May 2024 | PairCorr |
| 0.44 | MTD | Mettler Toledo Inter | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 20th of May 2024
Reviva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Reviva Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Reviva Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Reviva Pharmaceuticals report their recommendations after researching Reviva Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Reviva Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Reviva Pharmaceuticals. The Reviva consensus assessment is calculated by taking the average forecast from all of the analysts covering Reviva Pharmaceuticals. | |||||
Reviva Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Reviva Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Reviva Pharmaceuticals' financial leverage. It provides some insight into what part of Reviva Pharmaceuticals' total assets is financed by creditors.
| |||||
Reviva Pharmaceuticals Holdings (RVPH) is traded on NASDAQ Exchange in USA. It is located in 19925 Stevens Creek Boulevard, Cupertino, CA, United States, 95014 and employs 15 people. Reviva Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 82.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Reviva Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Reviva Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Reviva Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 27.92 M outstanding shares of which 1.23 M shares are at this time shorted by private and institutional investors with about 3.37 trading days to cover.
Reviva Pharmaceuticals Holdings currently holds about 23.19 M in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.13.
Check Reviva Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationReviva Pharmaceuticals has a total of 27.92 Million outstanding shares. Reviva Pharmaceuticals holds 17.71 pct. of its outstanding shares held by insiders and 17.93 pct. owned by third-party entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Reviva Ownership Details
Reviva Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Reviva Pharmaceuticals jumping above the current price in 90 days from now is more than 94.0%. The Reviva Pharmaceuticals Holdings probability density function shows the probability of Reviva Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings has a beta of -0.9707 indicating Additionally, reviva Pharmaceuticals Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Reviva Pharmaceuticals to move above the current price in 90 days from now is more than 94.0 (This Reviva Pharmaceuticals Holdings probability density function shows the probability of Reviva Stock to fall within a particular range of prices over 90 days) .
Reviva Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Reviva Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Reviva Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Reviva Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Man Group Plc | 49.2 K | ||
| Simplex Trading, Llc | 2023-12-31 | 45.2 K | |
| Two Sigma Investments Llc | 2023-12-31 | 41.6 K | |
| Northern Trust Corp | 2023-12-31 | 40.2 K | |
| Marshall Wace Asset Management Ltd | 2023-12-31 | 39.1 K | |
| Tower Research Capital Llc | 2023-12-31 | 38 K | |
| Qube Research & Technologies | 2023-12-31 | 35.4 K | |
| Jane Street Group, Llc | 2023-12-31 | 29.1 K | |
| Virtu Financial Llc | 2023-12-31 | 15.2 K | |
| Armistice Capital, Llc | 2023-12-31 | 1.8 M | |
| Vanguard Group Inc | 2023-12-31 | 975 K |
Reviva Pharmaceuticals Historical Income Statement
Reviva Pharmaceuticals Holdings Income Statement is one of the three primary financial statements used for reporting Reviva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Reviva Pharmaceuticals revenue and expense. Reviva Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Reviva Pharmaceuticals' Other Operating Expenses is increasing as compared to previous years. The Reviva Pharmaceuticals' current Research Development is estimated to increase to about 33 M, while Interest Expense is projected to decrease to under 156.3 K. View More FundamentalsReviva Stock Against Markets
Picking the right benchmark for Reviva Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Reviva Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Reviva Pharmaceuticals is critical whether you are bullish or bearish towards Reviva Pharmaceuticals Holdings at a given time. Please also check how Reviva Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Reviva Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
How to buy Reviva Stock?
Before investing in Reviva Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Reviva Pharmaceuticals. To buy Reviva Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Reviva Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Reviva Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Reviva Pharmaceuticals Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Reviva Pharmaceuticals Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Reviva Pharmaceuticals Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Reviva Stock please use our How to Invest in Reviva Pharmaceuticals guide.
Already Invested in Reviva Pharmaceuticals Holdings?
The danger of trading Reviva Pharmaceuticals Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Reviva Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Reviva Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Reviva Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Reviva Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.65) | Return On Assets (1.16) | Return On Equity (5.56) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.